Outcomes of patients receiving extracorporeal membrane oxygenation: Direct vs consultative advanced heart failure and transplant cardiology physicians’ role

doi:10.5500/wjt.v15.i4.108372

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=0

Dec 18, 2025 (publication date) through Nov 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Transplant. Dec 18, 2025; 15(4): 108372
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.108372

Open in New Tab Full Size Figure Download Figure

Figure 1 Comparison of survival outcomes in a cohort of extracorporeal membrane oxygenation patients with direct vs consultative advanced heart failure and transplant involvement. TSAD: Total survival after decannulation; TSADWCAHFTCR: Total survival after decannulation with consultative advanced heart failure and transplant cardiology role; TSADWDAHFTCR: Total survival after decannulation with direct advanced heart failure and transplant cardiology role; TST30DPD: Total survival to 30 days post discharge; TST30DPDWCAHFTCR: Total survival to 30 days post discharge with consultative advanced heart failure and transplant cardiology role; TST30DPDWDAHFTCR: Total survival to 30 days post discharge with direct advanced heart failure and transplant cardiology role; TVASAD: Total veno-arterial survival after decannulation; TVAST30DPD: Total veno-arterial survival to 30 days post discharge; TVVSAD: Total veno-venous survival after decannulation; TVVST30DPD: Total veno-venous survival to 30 days post discharge; VASADWCAHFTCR: Veno-arterial survival after decannulation with consultative advanced heart failure and transplant cardiology role; VASADWDAHFTCR: Veno-arterial survival after decannulation with direct advanced heart failure and transplant cardiology role; VAST30DPDWCAHFTCR: Veno-arterial survival to 30 days post discharge with consultative advanced heart failure and transplant cardiology role; VAST30DPDWDAHFTCR: Veno-arterial survival to 30 days post discharge with direct advanced heart failure and transplant cardiology role; VVSADWCAHFTCR: Veno-venous survival after decannulation with consultative advanced heart failure and transplant cardiology role; VVSADWDAHFTCR: Veno-venous survival after decannulation with direct advanced heart failure and transplant cardiology role; VVST30DPDWCAHFTCR: Veno-venous survival to 30 days post discharge with consultative advanced heart failure and transplant cardiology role; VVST30DPDWDAHFTCR: Veno-venous survival to 30 days post discharge with direct advanced heart failure and transplant cardiology role.

Citation: Feyissa GD. Outcomes of patients receiving extracorporeal membrane oxygenation: Direct vs consultative advanced heart failure and transplant cardiology physicians’ role. World J Transplant 2025; 15(4): 108372
URL: https://www.wjgnet.com/2220-3230/full/v15/i4/108372.htm
DOI: https://dx.doi.org/10.5500/wjt.v15.i4.108372